Because of margin and market growth pressures, life sciences supply chains are more dynamic than ever before. In 2009, best practice companies will continue to put in place data analysis processes and "human knowledge" collection procedures to spot red flags and safety risks in their end-to-end supply chains.
Core high-tech consists of semiconductors, contract & design manufacturing, original equipment manufacturing, consumer electronics, and telecommunications. Most companies in this segment are highly impacted by the economic downturn, trying to reduce working capital, and segmenting product decisions based on profitability.
2009 is certainly shaping up to be a difficult year for manufacturers. Tight credit markets, poor consumer confidence and retail sales, along with low manufacturing activity, suggests that overall supply chain investment activity will be reduced and cost-savings activities will be prioritized.